Economics at your fingertips  


Bertrand Pauget () and Xavier Parisot
Additional contact information
Bertrand Pauget: European Business School, Paris, France
Xavier Parisot: European Business School, Paris, France

Scientific Bulletin - Economic Sciences, 2013, vol. 12, issue 2, 85-94

Abstract: There is in France and more generally in Europe a paradox. In the agro industry business, the use of biotechnology is suspicious and controversy (see for example the emblematic case of GMOs), the subject is little debate in the health sector. Yet, in those two sectors, the production process of biotechnology is the same. How can we explain those differences? This article aims to explain the reasons for the acceptance of biotechnology in the business of health. Health professionals interviewed in this study leave use the biotechnology as a tool to improve their practices and benefiting their patients. In doing so, they play a key role to facilitate their consumption by the public. This article is based on a qualitative and exploratory methodology. Our sample consists of leaders of biotech companies or selling biotechnology and doctors who use them.

Keywords: biotechnology; acceptance; technological assimilation; identity. (search for similar items in EconPapers)
JEL-codes: I19 L20 (search for similar items in EconPapers)
Date: 2013
References: View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link) (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Access Statistics for this article

Scientific Bulletin - Economic Sciences is currently edited by Alina Hagiu

More articles in Scientific Bulletin - Economic Sciences from University of Pitesti Contact information at EDIRC.
Bibliographic data for series maintained by Alina Hagiu ().

Page updated 2022-12-07
Handle: RePEc:pts:journl:y:2013:i:2:p:85-94